Literature DB >> 14627842

Suppression of gene expression by a cell-permeable Tet repressor.

Alison Mortlock1, Walter Low, Andrea Crisanti.   

Abstract

Engineered transcription factors designed to selectively activate or repress endogenous genes have great potential in medical and biotechnological applications. Ultimately, their success will depend on the development of efficient delivery systems. We show here that a chimeric tetracycline- controlled transcription factor, encompassing the Tet repressor (TetR) from the tetracycline-resistance operon (tet from Escherichia coli transposon Tn10) and a cell membrane transducing peptide, is able to regulate transcription from a tetracycline responsive promoter (pCMV2xtetO2). When added directly to cultured cells, TetR fused to the full-length Antennapedia homeodomain (AntpHD) from Drosophila (TetRAntp), was able to selectively repress transcription in cells transiently transfected with a tetracycline-regulated reporter transcription unit. Moreover, TetRAntp could repress expression of a tetracycline responsive reporter transcription unit stably integrated into the genome of HeLa cells, demonstrating the possibility of manipulating endogenous gene expression by cell-permeable transcription factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14627842      PMCID: PMC290287          DOI: 10.1093/nar/gng152

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  40 in total

1.  Positive and negative regulation of endogenous genes by designed transcription factors.

Authors:  R R Beerli; B Dreier; C F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Is VP22 nuclear homing an artifact?

Authors:  M Lundberg; M Johansson
Journal:  Nat Biotechnol       Date:  2001-08       Impact factor: 54.908

3.  Protein delivery using VP22.

Authors:  Robert P Bennett; Brian Dalby; Pamela M Guy
Journal:  Nat Biotechnol       Date:  2002-01       Impact factor: 54.908

4.  Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase.

Authors:  D Jo; A Nashabi; C Doxsee; Q Lin; D Unutmaz; J Chen; H E Ruley
Journal:  Nat Biotechnol       Date:  2001-10       Impact factor: 54.908

5.  A highly potent artificial transcription factor.

Authors:  Dusan Stanojevic; Richard A Young
Journal:  Biochemistry       Date:  2002-06-11       Impact factor: 3.162

6.  Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans.

Authors:  M Tyagi; M Rusnati; M Presta; M Giacca
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

7.  Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes.

Authors:  S Neil; F Martin; Y Ikeda; M Collins
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

8.  Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes.

Authors:  Michael Peitz; Kurt Pfannkuche; Klaus Rajewsky; Frank Edenhofer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

Review 9.  Synthetic DNA delivery systems.

Authors:  D Luo; W M Saltzman
Journal:  Nat Biotechnol       Date:  2000-01       Impact factor: 54.908

10.  Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands.

Authors:  Y Liu; M Jones; C M Hingtgen; G Bu; N Laribee; R E Tanzi; R D Moir; A Nath; J J He
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

View more
  3 in total

1.  Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis.

Authors:  Xuling Huang; Courtney Brown; Weihua Ni; Elizabeth Maynard; Alan C Rigby; Peter Oettgen
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

2.  Virus-Like Particles Derived from HIV-1 for Delivery of Nuclear Proteins: Improvement of Production and Activity by Protein Engineering.

Authors:  Marc-André Robert; Viktoria Lytvyn; Francis Deforet; Rénald Gilbert; Bruno Gaillet
Journal:  Mol Biotechnol       Date:  2017-01       Impact factor: 2.695

3.  The role of ets factors in tumor angiogenesis.

Authors:  Peter Oettgen
Journal:  J Oncol       Date:  2010-05-04       Impact factor: 4.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.